array:24 [ "pii" => "S2387020620302540" "issn" => "23870206" "doi" => "10.1016/j.medcle.2019.04.056" "estado" => "S300" "fechaPublicacion" => "2020-07-24" "aid" => "4884" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2019" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2020;155:88-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0025775319304026" "issn" => "00257753" "doi" => "10.1016/j.medcli.2019.04.026" "estado" => "S300" "fechaPublicacion" => "2020-07-24" "aid" => "4884" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2020;155:88-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>" "titulo" => "Cierre de orejuela izquierda como alternativa a la anticoagulación en la fibrilación auricular" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "88" "paginaFinal" => "89" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Left atrial appendage occlusion as an alternative to anticoagulation in patients with atrial fibrillation" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Gemma Rodríguez Villadeamigo, Jose Luis Gómez Reyes, Miguel Pedregal González" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Gemma" "apellidos" => "Rodríguez Villadeamigo" ] 1 => array:2 [ "nombre" => "Jose Luis" "apellidos" => "Gómez Reyes" ] 2 => array:2 [ "nombre" => "Miguel" "apellidos" => "Pedregal González" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2387020620302540" "doi" => "10.1016/j.medcle.2019.04.056" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020620302540?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775319304026?idApp=UINPBA00004N" "url" => "/00257753/0000015500000002/v1_202007120611/S0025775319304026/v1_202007120611/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2387020620302564" "issn" => "23870206" "doi" => "10.1016/j.medcle.2019.05.027" "estado" => "S300" "fechaPublicacion" => "2020-07-24" "aid" => "4929" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2020;155:89-90" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Median arcuate ligament syndrome and upper gastrointestinal bleeding" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "89" "paginaFinal" => "90" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Síndrome del ligamento arcuato mediano y hemorragia digestiva alta" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Javier A. Cienfuegos, Fernando Rotellar, Luis Hurtado-Pardo" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Javier A." "apellidos" => "Cienfuegos" ] 1 => array:2 [ "nombre" => "Fernando" "apellidos" => "Rotellar" ] 2 => array:2 [ "nombre" => "Luis" "apellidos" => "Hurtado-Pardo" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775319304518" "doi" => "10.1016/j.medcli.2019.05.029" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775319304518?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020620302564?idApp=UINPBA00004N" "url" => "/23870206/0000015500000002/v1_202007190713/S2387020620302564/v1_202007190713/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S2387020620302606" "issn" => "23870206" "doi" => "10.1016/j.medcle.2020.04.006" "estado" => "S300" "fechaPublicacion" => "2020-07-24" "aid" => "5185" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2020;155:87-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Clinical characteristics of 11 asymptomatic patients with COVID-19" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "87" "paginaFinal" => "88" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Características clínicas de 11 pacientes asintomáticos con COVID-19" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Bao Fu, Xiaoyun Fu" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Bao" "apellidos" => "Fu" ] 1 => array:2 [ "nombre" => "Xiaoyun" "apellidos" => "Fu" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020620302606?idApp=UINPBA00004N" "url" => "/23870206/0000015500000002/v1_202007190713/S2387020620302606/v1_202007190713/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Left atrial appendage occlusion as an alternative to anticoagulation in patients with atrial fibrillation" "tieneTextoCompleto" => true "saludo" => "Dear Editor:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "88" "paginaFinal" => "89" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Gemma Rodríguez Villadeamigo, Jose Luis Gómez Reyes, Miguel Pedregal González" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Gemma" "apellidos" => "Rodríguez Villadeamigo" "email" => array:1 [ 0 => "gemmardv@hotmail.com" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Jose Luis" "apellidos" => "Gómez Reyes" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 2 => array:3 [ "nombre" => "Miguel" "apellidos" => "Pedregal González" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Hospital Infanta Elena, Huelva, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Centro de Salud el Torrejón, Huelva, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Servicio de Cardiología, Hospital Infanta Elena, Huelva, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Unidad Docente de MFyC, Huelva, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Cierre de orejuela izquierda como alternativa a la anticoagulación en la fibrilación auricular" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">For years, the only alternative to heparin has been vitamin K antagonists (VKA), until the arrival of direct oral anticoagulants (DOAC). However, they are not exempt from haemorrhagic risk due to their own anticoagulant effect, they have limitations for patients with kidney failure and may have side effects.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Several studies have shown that the main source of thrombi in patients with atrial fibrillation (AF) is the left atrial appendage (LAA), so its removal by surgical excision or by percutaneous techniques reduces the rate of thromboembolic events and allows to eliminate anticoagulant treatment.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">1,2</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">We report the case of an 84-year-old female, independent for the basic activities of daily living, with a history of: hypertension, paroxysmal AF, mild mitral and aortic regurgitation, dyslipidaemia, obesity, chronic anaemia and right hemicolectomy due to colorectal cancer. A year before, treatment with acenocoumarol was discontinued due to INR instability and epistaxis, and she was anticoagulated with enoxaparin. Currently on treatment with: bisoprolol 2.5<span class="elsevierStyleHsp" style=""></span>mg/24<span class="elsevierStyleHsp" style=""></span>h, simvastatin 20<span class="elsevierStyleHsp" style=""></span>mg/24<span class="elsevierStyleHsp" style=""></span>h, furosemide 40<span class="elsevierStyleHsp" style=""></span>mg/24<span class="elsevierStyleHsp" style=""></span>h and enoxaparin 60<span class="elsevierStyleHsp" style=""></span>mg/24<span class="elsevierStyleHsp" style=""></span>h.</p><p id="par0020" class="elsevierStylePara elsevierViewall">An assessment of her anticoagulation treatment was carried out by the cardiology department.</p><p id="par0025" class="elsevierStylePara elsevierViewall">During history-taking, she reported prolonged asthenia, an emergency department visit 2 months earlier due to palpitations (the last episode of AF reported) and frequent epistaxis during the previous month.</p><p id="par0030" class="elsevierStylePara elsevierViewall">The only finding on examination was a grade II/VI systolic murmur with preserved second heart sound. An electrocardiogram was performed in the cardiology clinic (sinus rhythm at 68<span class="elsevierStyleHsp" style=""></span>bpm, preserved AV conduction, without intraventricular conduction or repolarization abnormalities) and several ancillary tests were requested and reviewed in a subsequent visit: the transthoracic echocardiography showed a slightly dilated left atrium with an area of 26<span class="elsevierStyleHsp" style=""></span>cm<span class="elsevierStyleSup">2</span>, an non-dilated left ventricle with preserved ejection fraction, normal right cavities, mild and degenerative aortic and mitral regurgitation, as well as moderate tricuspid regurgitation that allowed the assessment of mild pulmonary hypertension.</p><p id="par0035" class="elsevierStylePara elsevierViewall">Blood pressure Holter monitoring did not show any abnormalities and a laboratory test highlighted macrocytic hypochromic anaemia with haemoglobin levels of 7<span class="elsevierStyleHsp" style=""></span>g/dl, creatinine clearance of 35<span class="elsevierStyleHsp" style=""></span>ml/min and a ProBNP of 6796<span class="elsevierStyleHsp" style=""></span>pg/ml; with the rest of values being normal.</p><p id="par0040" class="elsevierStylePara elsevierViewall">With all this, the following presumptive diagnosis was obtained: Paroxysmal AF, CHADVASC score: 4 (high thromboembolic risk), HAS-BLED: 5 (high risk of bleeding) and HEMORR<span class="elsevierStyleInf">2</span>HAGES: 6 (high risk of bleeding), in a patient with moderate stage 3 kidney disease.</p><p id="par0045" class="elsevierStylePara elsevierViewall">Due to external bleeding, INR instability and borderline renal function for severity (independent risk factor for bleeding), it was appropriate to consider an alternative treatment, such as percutaneous occlusion of the LAA. Anticoagulated with apixaban 2.5<span class="elsevierStyleHsp" style=""></span>mg/12<span class="elsevierStyleHsp" style=""></span>h during the time the patient considered the interventional option.</p><p id="par0050" class="elsevierStylePara elsevierViewall">The patient was asked to return one month later and accepted the percutaneous procedure, requesting a transoesophageal ultrasound to measure ostium and LAA depth (with a view to deciding on the size of the device to be used). The procedure was performed without complications, implanting an Amplatzer® device, discontinuing apixaban and continuing with aspirin 100<span class="elsevierStyleHsp" style=""></span>mg/24<span class="elsevierStyleHsp" style=""></span>h.</p><p id="par0055" class="elsevierStylePara elsevierViewall">There are 4 scales of haemorrhagic risk.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> The most popular is HAS-BLED, but HEMORR<span class="elsevierStyleInf">2</span>HAGES is the only one that takes neoplastic disease into account as a bleeding risk factor. Some scale that recognizes neoplastic disease as a thromboembolic factor is missing in the management of these patients.</p><p id="par0060" class="elsevierStylePara elsevierViewall">Despite studies showing that percutaneous closure of LAA reduces the rate of thromboembolic events and allows the elimination of anticoagulant treatment,<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">1,4,5</span></a> it seems that oral treatments are still the treatment of choice. Only the following cases would be candidates for atrial appendage occlusion: patients with nonvalvular AF with life expectancy ≥<span class="elsevierStyleHsp" style=""></span>1 year, significant thromboembolic risk (CHADS<span class="elsevierStyleHsp" style=""></span>≥<span class="elsevierStyleHsp" style=""></span>2) and very high bleeding risk (HAS-BLED<span class="elsevierStyleHsp" style=""></span>≥<span class="elsevierStyleHsp" style=""></span>3) or an absolute contraindication for long-term anticoagulation.</p><p id="par0065" class="elsevierStylePara elsevierViewall">In conclusion, a percutaneous occlusion procedure was considered the most effective option, since on the one hand the treatment with VKA associated great INR instability and on the other hand the use of DOAC was compromised by borderline renal failure for severity and did not prevent frequent epistaxis.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Rodríguez Villadeamigo G, Gómez Reyes JL, Pedregal González M. Cierre de orejuela izquierda como alternativa a la anticoagulación en la fibrilación auricular. Med Clin (Barc). 2020;155:88–89.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tratamiento no farmacológico de la fibrilación auricular. Ablación, cardioversión eléctrica, marcapasos y cierre de la orejuela" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "F. Atienza" 1 => "A. Moya" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1131-3587(16)30013-9" "Revista" => array:6 [ "tituloSerie" => "Rev Esp Cardiol" "fecha" => "2016" "volumen" => "16" "numero" => "Suppl. A" "paginaInicial" => "40" "paginaFinal" => "46" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Definición del papel de la oclusión de la orejuela auricular izquierda en la fibrilación auricular" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "F. Andreotti" 1 => "F. Crea" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.recesp.2012.09.013" "Revista" => array:6 [ "tituloSerie" => "Rev Esp Cardiol" "fecha" => "2013" "volumen" => "66" "paginaInicial" => "79" "paginaFinal" => "82" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24775378" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Escalas de evaluación del riesgo tromboembólico y hemorrágico en la fibrilación auricular" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J. Pérez-Copete" 1 => "M.A. Esteve-Pastor" 2 => "V. Roldán" 3 => "M. Valdés" 4 => "F. Marín" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1131-3587(16)30011-5" "Revista" => array:6 [ "tituloSerie" => "Rev Esp Cardiol" "fecha" => "2016" "volumen" => "16" "numero" => "Suppl. A" "paginaInicial" => "25" "paginaFinal" => "32" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Selección de lo mejor del año 2017 en cierre percutáneo de la orejuela izquierda: completando la evidencia científica" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A. Pérez de Prado" 1 => "A. Serrador" 2 => "P. Jiménez-Quevedo" 3 => "T. Benito González" 4 => "F. Fernández Vázquez" 5 => "M. Pan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.recesp.2017.10.016" "Revista" => array:6 [ "tituloSerie" => "Rev Esp Cardiol" "fecha" => "2018" "volumen" => "71" "paginaInicial" => "225" "paginaFinal" => "227" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29352720" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF Trials" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "V.Y. Reddy" 1 => "S.K. Doshi" 2 => "S. Kar" 3 => "D.N. Gibson" 4 => "M.J. Price" 5 => "K. Huber" 6 => "PREVAIL and PROTECT AF Investigators" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jacc.2017.10.021" "Revista" => array:6 [ "tituloSerie" => "J Am Coll Cardiol" "fecha" => "2017" "volumen" => "70" "paginaInicial" => "2964" "paginaFinal" => "2975" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29103847" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/23870206/0000015500000002/v1_202007190713/S2387020620302540/v1_202007190713/en/main.assets" "Apartado" => array:4 [ "identificador" => "43309" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23870206/0000015500000002/v1_202007190713/S2387020620302540/v1_202007190713/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020620302540?idApp=UINPBA00004N" ]
Journal Information
Vol. 155. Issue 2.
Pages 88-89 (July 2020)
Share
Download PDF
More article options
Vol. 155. Issue 2.
Pages 88-89 (July 2020)
Letter to the Editor
Left atrial appendage occlusion as an alternative to anticoagulation in patients with atrial fibrillation
Cierre de orejuela izquierda como alternativa a la anticoagulación en la fibrilación auricular
Visits
2
This item has received
Article information
These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscribe
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail